Macquarie Group’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-856
| Closed | -$4 | – | 2094 |
|
|
2024
Q1 | $4 | Buy |
+856
| New | +$4 | ﹤0.01% | 1817 |
|
|
2022
Q4 | – | Hold |
0
| – | -$4K | – | 2244 |
|
|
2022
Q3 | – | Sell |
-116
| Closed | -$2K | – | 2458 |
|
|
2022
Q2 | $2K | Hold |
116
| – | – | ﹤0.01% | 2559 |
|
|
2022
Q1 | $3 | Hold |
116
| – | – | ﹤0.01% | 2601 |
|
|
2021
Q4 | $3K | Hold |
116
| – | – | ﹤0.01% | 2584 |
|
|
2021
Q3 | $3K | Hold |
116
| – | – | ﹤0.01% | 2609 |
|
|
2021
Q2 | $4K | Hold |
116
| – | – | ﹤0.01% | 2535 |
|
|
2021
Q1 | $4K | Sell |
116
-55
| -32% | -$1.9K | ﹤0.01% | 2452 |
|
|
2020
Q4 | $5K | Hold |
171
| – | – | ﹤0.01% | 2342 |
|
|
2020
Q3 | $6K | Hold |
171
| – | – | ﹤0.01% | 2327 |
|
|
2020
Q2 | $8K | Sell |
171
-2,705
| -94% | -$127K | ﹤0.01% | 2311 |
|
|
2020
Q1 | $98K | Buy |
+2,876
| New | +$98K | ﹤0.01% | 1641 |
|